An oncolytic virus with strong appetence for the most aggressive type of pancreatic cancer cells
Oncolytic virus,
pancreatic cancer,
precision medicine
Pierre Cordelier – Team ImPact – Therapeutic innovation in pancreatic cancer
The Minute virus of mice (MVMp) is a small-sized DNA virus belonging to the Parvoviridae family. Harmless to humans, it infects various animal species, including mice, without being pathogenic. Our work demonstrates for the first time that this virus targets the most aggressive type of pancreatic cancer cells. While normal cells and more differentiated cancer cells are spared by the virus, MVM infects, replicates, and kills pancreatic cancer cells of murine or human origin that exhibit a mesenchymal profile, which is generally recognized as the source of resistance of these tumors to treatments. In experimental tumor models, viral infection blocks tumor progression and facilitates the recruitment of antitumoral immune cells into tumors.
This work represents, to our knowledge, one of the very first examples of precision virotherapy, in which the phenotype of tumor cells could be predictive of the anticancer efficacy of oncolytic viruses. This study also opens the door to combining virotherapy and immunotherapy for the management of the most aggressive pancreatic tumors.”
Discover the published article
Mol Ther Oncol. 2024 Feb 22;32(1):200780. doi: 10.1016/j.omton.2024.200780. eCollection 2024 Mar 21.PMID: 38596307
Minute virus of mice shows oncolytic activity against pancreatic cancer cells exhibiting a mesenchymal phenotype.
Vienne M, Lopez C, Lulka H, Nevot A, Labrousse G, Dusetti N, Buscail L, Cordelier P.
Collaborations and partnerships
Collaborations
-
Nelson Dusetti, CRCM
-
Louis Buscail, CHU de Toulouse
Funding
- Fondation ARC
Toulouse Cancer Research Center (Oncopole)
Toulouse - FR
Contact us
+33 5 82 74 15 75
Want to join
the CRCT team ?